Tapering Prednisone After Prolonged High-Dose Therapy

Side Effects and Complications

Up to 80% of patients develop adverse effects after 2 years of prednisone therapy, with patients at 9 months already in the high-risk zone 1, 2
Severe adverse effects occur mainly at doses >20mg/day for more than 18 months and lead to treatment discontinuation in about 15% of patients 1, 2
Cosmetic changes, such as weight gain, facial rounding, and hirsutism, are nearly universal at this dose and duration 1, 2
Metabolic complications, including diabetes or impaired glucose tolerance, hypertension, and dyslipidemia, are common 3, 1
Bone health is a major concern, with osteoporosis requiring calcium and vitamin D supplementation and bone mineral density testing 3, 4
Psychiatric effects, including emotional instability, mood swings, anxiety, depression, or even psychosis, can occur 1, 2, 4

HPA axis suppression is guaranteed after 9 months at 60mg/day, exceeding the threshold of >7.5mg for >3 weeks 3, 4
Adrenal insufficiency may persist for up to 12 months after discontinuation, requiring stress-dose steroids for any significant illness or surgery during tapering and for up to 12 months after discontinuation 3
The American College of Rheumatology recommends monitoring for adrenal insufficiency symptoms, such as fatigue, weakness, dizziness, nausea, and hypotension, during the tapering process 5

Rapid tapering is a common mistake that leads to symptom recurrence, and disease relapse rates are higher with abrupt discontinuation compared to gradual taper 4, 5
Monitor for signs of the underlying condition worsening at each dose reduction, and consider adding steroid-sparing agents before or during the taper to reduce relapse risk 5, 4

For a patient on 60mg/day for 9 months, use a slow, structured taper, reducing by 5mg every week until reaching 10mg/day, then slowing the taper to 2.5mg reductions every week once at 10mg/day 5
When reaching ≤5mg/day, consider even slower tapering (1mg monthly) due to adrenal insufficiency risk 4, 6

Follow-up visits every 4-8 weeks during the first year, monitoring for disease relapse, adrenal insufficiency symptoms, and ongoing management of long-term complications, such as osteoporosis, gastric protection, and cardiovascular risk modification 5, 3
Consider morning cortisol or ACTH stimulation testing when reaching physiologic doses (≤7.5mg) to assess adrenal recovery 4

If the underlying condition allows, consider adding steroid-sparing agents before or during the taper to reduce relapse risk, such as azathioprine, which reduces steroid side effects from 44% to 10% compared to prednisone alone 5, 4, 7, 2